STOCK TITAN
  1. Home
  2. News
  3. REVB

Revelation Biosciences Inc - REVB STOCK NEWS

IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. to Participate in a Fireside Chat at the 35th Annual Roth Conference
conferences
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Closing of $15.6 Million Public Offering
offering
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Pricing of $15.6 Million Public Offering
offering
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Preclinical Biomarker Data Supporting Activity of REVTx-300
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces 1-for-35 Reverse Stock Split effective February 1, 2023 and Results of Special Meeting of Stockholders
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Mandatory Unit Separation to Occur on January 13, 2023
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Future Clinical Development Plans Based on Recent Biomarker Analysis and Significant Reduction in New Collagen Deposition (Fibrosis) in Preclinical Model
clinical trial
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Recent Corporate Progress
earnings
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. Announces Positive Results in Preclinical Model of Acute and Chronic Kidney Disease
IMPACT
SENTIMENT
REVB : Nasdaq
Revelation Biosciences Inc. and Vanderbilt University Enter Exclusive Worldwide License Agreement
Stock REVB logo
Revelation Biosciences Inc

Nasdaq:REVB

REVB Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

REVB Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Regional Banks, Finance

About REVB

we develop immunologic therapeutics and diagnostics designed to make the world a healthier place